As a global network, Patient Connect delivers evidence-based clinical messages at the point of care As a pioneering team of clinicians and analysts, Patient Connect uses Artificial Intelligence to deliver great patient insights and deeper patient understanding Patient Connect's experienced team of expert clinicians and analysts create and deliver evidence-based digital messages that are proven to improve patient compliance and facilitate choice. Its patient-centric messaging can reach over 400 million individuals around the globe, empowering patients to make educated choices about their health and medication. Artificial intelligence techniques analyse changes in patient behaviour and demonstrate the effectiveness of its clinical programmes. Years of experience working with the world’s biggest pharma and clinical research organisations ensures that bespoke, cost-effective programmes meet client requirements and are delivered on time, every time. A Partner at MVM Life Science Partners says: “MVM sees hundreds of investment opportunities in a year and we have never seen a service with such impact on patients. We believe the measurable financial return, driven by improved compliance, will see Patient Connect migrate to be an indispensable element of any balanced sales and marketing campaign.”